> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# 3 NDAs Withdrawn Over Annual Reports
- URL: https://www.fdaweb.com/3-ndas-withdrawn-over-annual-reports/
- Published: 2022-07-22T12:00:00.000Z
- Updated: 2026-09-14T17:53:02.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5152338

*Federal Register* notice: FDA is withdrawing approval of three NDAs from multiple holders because they repeatedly failed to file required annual reports. They are:

- NDA 008284 — Panray Corp’s cortisone acetate tablets (5 mg and 25 mg)
- NDA 009659 — Panray Corp’s hydrocortisone tablets (10 mg and 20 mg)
- NDA 019503 — Parnell Pharmaceuticals’ triamcinolone acetonide suspension (3 mg/mL)